Together these results suggest that p110δ inhibition has potential to selectively block both intrinsic (BCR tonic) and extrinsic signals from the lymphoid tissue microenvironment promoting B-CLL survival and proliferation. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.